申请人:Mitsubishi Pharma Corporation
公开号:US07015218B1
公开(公告)日:2006-03-21
The present invention relates to a compound of the formula
wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X′ is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
本发明涉及一种化合物,其化学式为其中R1为取代芳基,杂环芳基等,R2和R3为氢,烷基,卤素,羟基等,Q为N,CH等,W为氢,烷基,羟基羧基烷基等,X为卤素,氰基,硝基,氨基等,X'为氢,卤素,氰基,硝基,Y为烷基,羟基,烷氧基,巯基等及其盐,以及包含所述化合物的药物。本发明的化合物显示出对活化淋巴细胞增殖的优越抑制作用,并可用作各种自身免疫性疾病的预防或治疗剂。